Why We should Assess Patients’ Expectations in Clinical Trials

被引：0
作者：
Elisa Frisaldi
Aziz Shaibani
Fabrizio Benedetti
机构：
[1] University of Turin Medical School,Neuroscience Department
[2] Nerve and Muscle Center,undefined
[3] Plateau Rosa Laboratories,undefined
[4] Plateau Rosa Laboratories,undefined
来源：
Pain and Therapy | 2017年 / 6卷
关键词：
Clinical trial; Expectation; Placebo effect;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Most of the analgesic clinical trials have failed to succeed over the past years because of the occurrence of large placebo responses. Patients’ expectations about the therapeutic benefit represent a major determinant of the placebo response. Therefore, assessing patients’ expectations should become the rule in any clinical trial. This would allow us to better interpret therapeutic outcomes when comparing placebo and verum groups.
引用
收藏
页码：107 / 110
页数：3
相关论文
共 50 条
[31]   The US FDA should consider increasing the number of patients required for new drug application clinical trials [J].
Reactions Weekly, 1999, 752 (1) :2-2
[32]   Use of composite outcomes to assess risk-benefit in clinical trials [J].
Shaw, Pamela A. .
CLINICAL TRIALS, 2018, 15 (04) :352-358
[33]   A first step to assess harm and benefit in clinical trials in one scale [J].
Boers, Maarten ;
Brooks, Peter ;
Fries, James F. ;
Simon, Lee S. ;
Strand, Vibeke ;
Tugwell, Peter .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2010, 63 (06) :627-632
[34]   Patient involvement in clinical trials: Motivation and expectations differ between patients and researchers involved in a trial on urinary tract infections [J].
Schilling I. ;
Behrens H. ;
Hugenschmidt C. ;
Liedtke J. ;
Schmiemann G. ;
Gerhardus A. .
Research Involvement and Engagement, 5 (1)
[35]   PROSPECTIVE REGISTRATION IN RHEUMATOLOGY RANDOMIZED CONTROLLED TRIALS: WHERE WE ARE, WHY, AND HOW WE COULD GET BETTER [J].
Capderou, S. ;
Mongin, D. ;
Agoritsas, T. ;
Courvoisier, D. S. ;
Iudici, M. .
ANNALS OF THE RHEUMATIC DISEASES, 2024, 83
[36]   Placebo Effect in Clinical Trials Involving Patients with Allergic Rhinitis [J].
del Cuvillo, A. ;
Sastre, J. ;
Bartra, J. ;
Mullol, J. ;
Davila, I. ;
Montoro, J. ;
Ferrer, M. ;
Jauregui, I. ;
Valero, A. .
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2011, 21 :40-45
[37]   Investigator clinical trials: How can we ask the question? [J].
Schved, Jean-Francois .
HAEMOPHILIA, 2020, 26 :20-21
[38]   Clinical characteristics and outcomes of patients enrolled in clinical trials compared with those of patients outside clinical trials in advanced gastric cancer [J].
Han, Jae Joon ;
Kim, Jin Won ;
Suh, Koung Jin ;
Kim, Ji-won ;
Kim, Se Hyun ;
Kim, Yu Jung ;
Kim, Jee Hyun ;
Lee, Jong Seok ;
Lee, Keun-Wook .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 (03) :158-165
[39]   Should we reconsider the routine use of placebo controls in clinical research? [J].
Avins, Andrew L. ;
Cherkin, Daniel C. ;
Sherman, Karen J. ;
Goldberg, Harley ;
Pressman, Alice .
TRIALS, 2012, 13
[40]   Should we reconsider the routine use of placebo controls in clinical research? [J].
Andrew L Avins ;
Daniel C Cherkin ;
Karen J Sherman ;
Harley Goldberg ;
Alice Pressman .
Trials, 13
12345